Is It Too Late To Consider Buying Orpea SA (EPA:ORP)?
Orpea SA ( EPA:ORP ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Has the French Healthcare Sector valuation changed over the past few years?
|Mon, 24 Jan 2022||€211.2b||€71.8b||€8.5b||20.8x|
|Wed, 22 Dec 2021||€222.0b||€71.7b||€8.5b||23.7x|
|Fri, 19 Nov 2021||€226.3b||€71.8b||€8.5b||23.7x|
|Sun, 17 Oct 2021||€216.3b||€70.5b||€8.1b||21.5x|
|Tue, 14 Sep 2021||€225.4b||€70.2b||€8.1b||25.9x|
|Thu, 12 Aug 2021||€223.8b||€70.2b||€8.1b||27.9x|
|Mon, 07 Jun 2021||€204.0b||€68.5b||€14.2b||28x|
|Sun, 28 Feb 2021||€187.8b||€67.9b||€14.0b||29x|
|Wed, 02 Dec 2020||€193.5b||€67.2b||€12.3b||30.4x|
|Sat, 05 Sep 2020||€191.2b||€66.3b||€11.7b||35x|
|Tue, 09 Jun 2020||€186.6b||€66.6b||€4.0b||28.3x|
|Mon, 02 Mar 2020||€167.7b||€65.7b||€3.3b||34.8x|
|Thu, 05 Dec 2019||€168.6b||€64.1b||€3.8b||36.2x|
|Sun, 08 Sep 2019||€157.3b||€63.1b||€4.4b||28.9x|
|Sat, 01 Jun 2019||€148.5b||€61.6b||€5.3b||29.4x|
|Tue, 05 Mar 2019||€146.9b||€60.0b||€5.2b||26.3x|
Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 20.8x which is lower than its 3-year average PE of 29.9x. It appears they believe that earnings will not grow as fast as they have historically.
Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 18% per year over the last three years, and revenues for these companies have grown 6.2% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the French Healthcare sector?
Industry PE: Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 34.7x. This is likely because analysts are expecting annual earnings growth of 19%, which is higher than its past year's earnings growth of 16% per year. Meanwhile, investors are most pessimistic about the Biotech industry, which is trading below its 3-year average of 19.3x.
Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 55% over the next 5 years. However this is lower than its past earnings growth rate of 158% per year. Meanwhile, the Medical Equipment industry is expected to see its earnings growth to stay flat over the next few years.
Which companies have driven the market over the last 7 days?
Sartorius Stedim Biotech
Bastide Le Confort Médical
Acticor Biotech SAS